Publications

Sort by: Date | Author | Title

Munch-Petersen, H. D., Asmar, F., Dimopoulos, K., Areškevičiūtė, A., Brown, P., Girkov, M. S., Pedersen, A., Sjö, L. D., Heegaard, S., Broholm, H., Kristensen, L. S., Ralfkiaer, E. & Grønbæk, K. (2016). TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy. Acta Neuropathologica Communications, 4, 40. https://doi.org/10.1186/s40478-016-0307-6
Nast, A., Dreno, B., Bettoli, V., Mokos, Z. B., Degitz, K., Dressler, A. C., Finlay, A. Y., Hædersdal, M., Lambert, J., Arribas-Layton, M., Lomholt, H. B., Lopez-Estebaranz, J. L., Ochsendorf, F., Oprica, C., Rosumeck, S., Simonart, T., Werner, R. N. & Gollnick, H. (2016). European evidence-based (S3) guideline for the treatment of acne - update 2016-short version. Journal of the European Academy of Dermatology and Venereology. Supplement, 30(8), 1261-1268. https://doi.org/10.1111/jdv.13776
Nielsen, H. R., Nilbert, M., Petersen, J., Ladelund, S., Thomassen, M., Pedersen, I. S., Hansen, T. V. O., Skytte, A.-B., Borg, Å. & Therkildsen, C. (2016). BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population. Familial Cancer, 15(4), 507–512. https://doi.org/10.1007/s10689-016-9875-7